Anzeige
Mehr »
Login
Samstag, 24.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
East Africa Metals - Deal mit dem größten Goldproduzenten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KAVV ISIN: IE00B91XRN20 Ticker-Symbol: 0PT 
Tradegate
23.07.21
21:51 Uhr
44,400 Euro
+0,600
+1,37 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
PROTHENA CORPORATION PLC Chart 1 Jahr
5-Tage-Chart
PROTHENA CORPORATION PLC 5-Tage-Chart
RealtimeGeldBriefZeit
43,60044,80023.07.
44,00044,40023.07.

Aktuelle News zur PROTHENA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiProthena Corporation plc: Prothena to Present Data from Two of its Alzheimer's Disease Programs at the Alzheimer's Association International Conference 2021249DUBLIN, Ireland, July 20, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein...
► Artikel lesen
14.07.Biotech Stock Roundup: BIIB & PRTA Provide Updates, CLDX Up on Positive Data & More15
PROTHENA Aktie jetzt für 0€ handeln
14.07.Dublin-based Prothena to sell drug to Novo Nordisk in $1.2bn deal20
13.07.Novo Nordisk Acquires Prothena's ATTR Program for $1.2B8
13.07.Prothena (PRTA) to Sell ATTR Amyloidosis Program to Novo Nordisk5
13.07.Novo Nordisk to acquire Prothena's ATTR amyloidosis programme for $1.2bn12
13.07.Novo Nordisk to buy Prothena's heart drug for up to $1.2 bln10
12.07.Prothena shares lag despite up to $1.2B deal with Novo Nordisk12
12.07.Novo Nordisk cardio push picks up Phase 2-ready Prothena drug in $100M deal11
12.07.Novo Nordisk signs deal for Prothena's heart drug worth up to $1.2bn12
12.07.PROTHENA CORP PUBLIC LTD CO - 8-K, Current Report1
12.07.Novo Nordisk puts $1.2B on the table for Prothena's ATTR drug, teeing up Alnylam challenge and cardiovascular expansion11
12.07.Novo Nordisk To Buy Prothena's ATTR Amyloidosis Program For Up To $1.2B5
12.07.Branching out from diabetes? Novo Nordisk shells out the big bucks for Prothena's ATTR amyloidosis pipeline7
12.07.Prothena Sells ATTR Amyloidosis Programme To Novo Nordisk For Up To $1.2 Bln1
12.07.Prothena sells amyloidosis portfolio to Novo Nordisk for up to $1.2 billion8
12.07.Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion9
12.07.Prothena Corporation plc: Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena's ATTR Amyloidosis Programme491Prothena is eligible to receive development and sales milestone payments totalling up to 1.2 billion US dollars, including 100 million dollars in upfront and near-term clinical milestone paymentsNovo...
► Artikel lesen
29.06.Prothena: Well-Positioned In Parkinson's And Alzheimer's5
24.06.PROTHENA CORP PUBLIC LTD CO - 8-K, Current Report3
Seite:  Weiter >>
91 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1